MedTrace Logo

Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging

NCT04086082 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-20

No results posted yet for this study

Summary

This trial will investigate the feasibility of the Markerless Tumour Tracking technology.

Conditions

Interventions

DEVICE

Markerless Image Guidance

Single arm trial using implanted markers to determine the feasibility of Markerless Image Guidance using Intrafraction Kilovoltage X-ray Imaging

Sponsors & Collaborators

  • University of Sydney

    lead OTHER

Principal Investigators

  • Paul Keall, PhD · University of Sydney

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-24
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04086082 on ClinicalTrials.gov